Key result
CHIP linked to ~40% higher cardiovascular event risk and increased all-cause mortality.
Why the study?
Despite growing evidence of the systemic impact of clonal hematopoiesis of indeterminate potential on cardiometabolic disease, screening remains limited to research settings, warranting a synthesis of epidemiological, mechanistic, and translational insights.
Design
Narrative review
Authors
Loading...
May refine CVD risk assessment in older adults; leaves open whether targeting CHIP alters outcomes.
Anastasiou et al. (2025) studied this question. Clonal hematopoiesis of indeterminate potential (CHIP) is associated with a 40% increased risk of cardiovascular disease events and a 34% rise in all-cause mortality among carriers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: